Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00645
Species: Homo sapiens
Position : chr11:8289240-8289522
Year: 2017
Title: APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  28260788
MONDO: MONDO:0004963
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF-10A
CVCL ID: CVCL_0598
Cell Type: breast epithelial cell
Experiment Type: Enhancer activity assay
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase Reporter Assay
About Target Gene
Target gene : LMO1
About TF
TF name : MYB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MYB AP-1 transcription factor network pid 71
MYB C-MYB transcription factor network pid 87
MYB Factors involved in megakaryocyte development and platelet production reactome 111
MYB IL2 signaling events mediated by PI3K pid 38
MYB IL4-mediated signaling events pid 66
MYB Notch-mediated HES/HEY network pid 48
MYB Prolactin netpath 105
MYB Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00043 chr11:8289240-8289522 blood T cell T-cell acute lymphoblastic leukemia
E_00044 chr11:8289240-8289522 blood T cell T-cell acute lymphoblastic leukemia
E_00045 chr11:8289240-8289522 blood T cell T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer